Cargando…
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
BACKGROUND AND AIMS: To examine the decongestive effect of the sodium-glucose cotransporter 2 inhibitor dapagliflozin compared to the thiazide-like diuretic metolazone in patients hospitalized for heart failure and resistant to treatment with intravenous furosemide. METHODS AND RESULTS: A multi-cent...
Autores principales: | Yeoh, Su Ern, Osmanska, Joanna, Petrie, Mark C, Brooksbank, Katriona J M, Clark, Andrew L, Docherty, Kieran F, Foley, Paul W X, Guha, Kaushik, Halliday, Crawford A, Jhund, Pardeep S, Kalra, Paul R, McKinley, Gemma, Lang, Ninian N, Lee, Matthew M Y, McConnachie, Alex, McDermott, James J, Platz, Elke, Sartipy, Peter, Seed, Alison, Stanley, Bethany, Weir, Robin A P, Welsh, Paul, McMurray, John J V, Campbell, Ross T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424881/ https://www.ncbi.nlm.nih.gov/pubmed/37210742 http://dx.doi.org/10.1093/eurheartj/ehad341 |
Ejemplares similares
-
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
por: Chatur, Safia, et al.
Publicado: (2023) -
Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling
por: Docherty, Kieran F., et al.
Publicado: (2020) -
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
por: Curtain, James P, et al.
Publicado: (2021) -
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
por: McMurray, John J V, et al.
Publicado: (2020) -
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
por: Docherty, Kieran F, et al.
Publicado: (2020)